Intriguingly, patients with lower CDC45 expression exhibited a more unfavorable survival prognosis in GC, consistent with findings in colorectal cancer (Hu et al., 2019), cervical squamous cell carcinoma and endocervical adenocarcinoma (Lu et al., 2022). The gene discussed is CDC45; the disease is endocervical adenocarcinoma.